Business Wire

Dave Powell’s “Vintage of the Century” to Be Sold via NFT

18.10.2021 22:00:00 EEST | Business Wire | Press release

Share

Celebrated winemaker Dave Powell will be the first vintner ever to sell an entire vintage by NFT, when he puts his 2021 single-vineyard vintage wines under the hammer on OpenSea, under his new brand Neldner Road.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005327/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Barrels of Neldner Road single-vineyard wines, which are being offered as individual NFTs on OpenSea. Visit www.neldnerroad.com.au. (Photo: Business Wire)

Powell, founder of Torbreck and more recently Powell & Son, said the decision to sell the vintage this way made sense.

“I’ve always liked to try new things and when I found out about NFTs, it seemed to fit,” he said. “This reminds me of how wines are sold in Bordeaux through their en primeur system. Like the more ‘traditional’ NFT products, our wine is rare – just 100 barrels; it’s unique – every vintage is different; and it’s the original collectible – the oldest personal wine collection dates back nearly 4,000 years.”

Powell has emulated ultra-luxury wine auctions like the Napa Wine Auction, and included within the NFTs one-of-a-kind experiences, such as:

  • Working a day’s vintage with Dave and his crew plus dinner together
  • The barrel bottled into personalised wine bottles
  • Wine cellared by Neldner Road
  • Barrel head with personalised plaque

Some barrels come with a hologram of the barrel, and there are exclusive travel and hospitality experiences with Dave for buyers who buy multiple NFTs or the entire vintage (details here).

Powell rebranded his internationally renowned wines as Neldner Road this year, in recognition of the “sense of place” that is the heart of his life’s work.

“These vineyards are some of the oldest in the world – older than the famous Bordeaux vineyards,” he said. “Over the last 100+ years they have developed rich, complex characters, which are reflected in each wine. It’s taken me 40 years to find these vineyards, work with the owners to rejuvenate them, and create these wines which are the best of my career.”

The 2021 Barossa vintage has been tipped as the best in living memory. “I’ve waited more than four decades to be in the right place at the right time,” Powell jokes. “I feel extraordinarily privileged to have secured the very best grapes from some of the most exceptional vineyards in the Barossa. The climatic conditions that led up to this vintage will never be repeated – I think these wines may well be the best I ever make.”

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information and interviews with Dave Powell:
Kristin Westlake | kwestlake@thecontinuumpartners.com | +61 416 219 358

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CAIRDAC Adds Operational Expertise to Its Board of Directors With the Appointment of Rinda Sama9.11.2026 14:44:00 EET | Press release

CAIRDAC, SA, a pre-revenue-stage medtech company developing ALPS™, a leadless, self-powered cardiac pacing system, today announced the appointment of Mr. Rinda Sama to its Board of Directors. His appointment adds deep manufacturing, quality and operational experience to the Board and follows the recent appointment of Raymond W. Cohen as Chairman. “Mr. Sama’s extensive experience in manufacturing, quality systems and operational scale-up for complex implantable devices will be extremely valuable to our Company as we prepare for clinical evaluation and the next stages of development,” said Edouard Fonck, Chief Executive Officer of CAIRDAC. Mr. Sama currently serves as CEO of Spiro Medical, a company focused on treating asthma employing a proprietary neuromodulation system. He previously served as Chief Operating Officer of publicly traded Axonics, Inc. where he was accountable for manufacturing and quality and the operational infrastructure that supported the company’s commercial growth.

Nominations Open for Sixth Edition of Aster Guardians Global Nursing Award 2027 Worth USD 250,000 Prize9.11.2026 14:35:00 EET | Press release

Aster DM Healthcare has announced the launch of the sixth edition of the Aster Guardians Global Nursing Award, inviting registered nurses worldwide to showcase their contributions to healthcare and compete for a prize of USD 250,000. The award recognises nurses whose work advances patient care, strengthens healthcare systems, drives innovation and transforms communities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261109180902/en/ Aster Guardians Global Nursing Award - One nurse will win the trophy and the prize of USD 250,000 (Photo: AETOSWire) Open to registered nurses worldwide, the award recognises contributions across five areas: Patient Care, Nursing Education, Social and Community Service, Research and Innovation, and Nursing Leadership and Administration. Applicants can share their professional journeys through case-study questions, in multiple languages at www.asterguardians.com until December 31, 2026. The 2026

Datavault AI and Biochar Now Combine Insured Carbon Removal Credits with Patented Tokenization Technology9.11.2026 13:45:00 EET | Press release

Datavault AI Inc. (“Datavault” or the “Company”) (Nasdaq: DVLT), today announced a global strategic collaboration with Biochar Now to expand the distribution of verified, insured carbon removal credits through Datavault’s patented tokenization technology and global marketing and distribution capabilities. The partnership is designed to connect Biochar Now’s carbon removal credits with a broader network of buyers while strengthening transparency, traceability and accountability in the carbon markets. Under the agreement, Datavault AI will provide access to its carbon credit tokenization technology, including U.S. Patent No. 12,443,977 and related pending applications. It will also support worldwide demand generation, buyer development, marketing and distribution of eligible Biochar Now carbon credits, while also pursuing listings with existing and future partner exchange platforms. Biochar Now will pay Datavault AI for its technology and services; specific financial terms were not discl

NIQ to Present at 2026 J.P. Morgan Ultimate Services Investor Conference9.11.2026 13:45:00 EET | Press release

NielsenIQ (NYSE: NIQ) (the “Company”, or “NIQ”), a leading global consumer intelligence company, today announced that Jim Peck, Chairman and CEO, and Mike Burwell, CFO will participate in a fireside chat at the J.P. Morgan Ultimate Services Investor Conference on Tuesday, November 17, 2026 at 2:40 pm ET. A live webcast will be available on the NIQ investor relations website at https://investors.nielseniq.com. A replay will also be available on the Company's website following the conclusion of the presentation. About NielsenIQ NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior. Combining an unmatched global data footprint, granular consumer and retail measurement, and decades of AI modeling expertise, NIQ helps companies turn complex data into confident action. With operations in more than 90 countries covering approximately 82% of the world’s population and more than $7.4 trillion in consumer spend, N

Compass Pathways Completes COMP360 Psilocybin New Drug Application to U.S. FDA for Treatment-Resistant Depression9.11.2026 13:30:00 EET | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the Company completed its submission of a New Drug Application (NDA) to the U.S. FDA for COMP360 psilocybin, its investigational synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD). "People living with treatment-resistant depression have gone too long experiencing disproportionate suffering, despite years of trying available treatment options without meaningful relief. The completion of our NDA submission reflects years of perseverance and commitment by patients, families, advocates, researchers and healthcare providers who have worked alongside us toward the shared goal of bringing new treatment options to this community,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “Compass is leading the development of this new class of medicines with rigor and discipline, successfully

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye